COPD: Magnesium in the plasma and polymorphonuclear cells of patients during a stable phase

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 4, Issue 1, 2007, Pages 41-47

  Ruljancic N ^a   Popovic Grle S ^b   Rumenjak, V ^c   Sokolic B ^d   Malic A ^a   Mihanovic M ^a   Cepelak I ^e  

^a brankarestek petrovic pbsvihr   (Croatia)

^b University Hospital for Lung Diseases Jordanovac   (Croatia)

^c Croatian Academy of Medical Sciences   (Croatia)

^d Croatia   (Croatia)

^e UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Chronic obstructive pulmonary disease; Ionized magnesium; Polymorphonuclear cells; Total magnesium

Indexed keywords

CALCIUM; CALCIUM ION; MAGNESIUM; MAGNESIUM ION;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CELL ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAGNESIUM BLOOD LEVEL; MALE; PATHOGENESIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RISK; SMOKING; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CALCIUM; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; MAGNESIUM; MALE; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUSCLES; SMOKING; SPIROMETRY;

EID: 33847389026     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550601169513     Document Type: Article

References (43)

1. Britton J, Pavord I, Richards K, Wisniewski A, Knox A, Lewis S, Tattersfield A, Weiss S. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet 1994; 344:357-362.
2. Rolla G, Bucca C. Hypomagnesaemia and bronchial hyperreactivity. A case report. Allergy 1989; 44:519-521.
3. Schroll A. Importance of magnesium for electrolyte homeostasis-An overview, In: Smetana R, ed. Advances in Magnesium Research 1: Magnesium in Cardiology. Vienna: John Libbey, 1995; 463-472.
4. Hasebe N. Oxidative stress and magnesium. Clin Calcium 2005; 15(2):194-202.
5. Crapo RO, Jensen RL, Hargrave FE. Airway inflammation in COPD: physiological outcome measures and induced sputum. Eur Respir J 2003; 21:19-28.
6. Agusto AGN, Noguera A, Salueda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21:347-360.
7. Tam M, Gomez S, Gonzales-Gross M, Marcos A. Possible roles of magnesium on the immune system. Eur J Clin Nutr 2003; 57(10):1193-1197.
8. Malpuech-Brugere C, Rock E, Astier C, Nowacki W, Mazur A, Rayssiguier Y. Exacerbated immune stress response during experimental magnesium deficiency results from abnormal cell calcium homeostasis. Life Sci 1998; 63:1815-1821.
9. Bussiere FI, Gueux E, Rock E, Mazur A, Rayssiguier Y. Protective effect of calcium deficiency on the inflammatory response in magnesium-deficient rats. Eur J Nutr 2002; 41:197-202.
10. Bussiere FI, Gueux E, Rock E, Girardeau JP, Tridon A, Mazur A. Increased phagocytosis and production of reactive oxygen species by neutrophil during magnesium deficiency in rats and inhibition by high magnesium concentration. Br J Nutr 2002; 87(2):107-113.
11. Rayssiguer Y, Mazur A. Magnesium and inflamation: Lessons from animal models. Clin Calcium 2005; 15(2):245-248.
12. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys. 2006 Apr 19; in press.
13. Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994; 94(6):2183-2192.
14. Skotnicki AB, Jablonski MJ, Musial J, Swadzba J. The role of magnesium in the pathogenesis and therapy of bronchial asthma. Przegl Lek 1997; 54(9):630-633.
15. Emelyanov A, Fedoseev G, Barnes PJ. Reduced intracellular magnesium concentration in asthmatic patients. Eur Respir J 1999; 13:38-40.
16. Bucca C, Rolla G. Nebulized magnesium in asthma: the right solution for an old remedy? Lancet 2003; 361:2095-2096.
17. Jenner R, Body R. Intravenous magnesium in COPD. Emer Med J 2004; 21(2):203.
18. Saris NEL, Mervaala E, Karppanen H, Khawaja J, Lewenstam A. Magnesium: an update on physiological, clinical and analytical aspects. Clinica Chimica Acta 2000; 294:1-26.
19. Elin RJ. Magnesium: The fifth but forgotten electrolyte. Am J Clin Pathol 1994; 102:616-622.
20. Ryschon TW, Rosenstein DL, Rubinov DR, Niemela JE, Elin RJ. Balaban RS. Relationship between skeletal muscles intracellular ionized magnesium and measurement of blood magnesium. J Lab Clin Med 1996; 127:207-213.
21. Altura BM, Altura BT. Role of magnesium in pathophysiological processes and the clinical utility of magnesium ion selective electrodes. Scand J Clin Lab Invest Suppl 1996; 224:211-234.
22. Elin RJ. Evaluating the role of ionized magnesium in laboratory and clinical practice, In: Smetana R, ed. Advances in Magnesium Research. 1. Magnesium in Cardiology. Vienna: John Libbey, 1995: 252-259.
23. Iseri T, French JH. Magnesium: Nature's physiologic calcium blocker. Am Heart J 1984; 108:193-189.
24. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1986; 21(97):77-89.
25. American Thoracic Society. Lung function testing: selection of reference value and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218.
26. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1256-1276.
27. Wouters EFM. Local and systemic inflammation in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2005; 2:26-33.
28. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001; 429(1-3):195-207.
29. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive disease. Am J Resp Cri Care 1997; 156:341-357.
30. Burnett D, Hill SL, Chamba A. Neutrophils from subjects with chronic lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 1987; 2:1043-1046.
31. Noguera A, Batle S, Miralles C, Iglesias I, Busquets X, Mec Nee W, Agusto AGN. Neutrophil response in chronic obstructive pulmonary disease. Thorax 2001; 56:432-437.
32. Noguera A, Busquets X, Salueda I, Vilaverde JM, Mac Nee W, Agusto AGN. Expression of molecules and G proteins in circulating neutrophils in chronic obstructive disease. Am J Resp Crit Care Med 1998; 158:1664-1668.
33. Cross A, Erickson R, Ellis BA, Curnutte JT. Spontaneous activation of NADPH oxidase in cell free system: unexpected multiple effects of magnesium ion concentrations. Biochem J 1999; 338:229-233.
34. Salueda J, Garcia Palmer FJ, Gonzales G, Palou A, Agusto AG. The activity of cytochrom oxidaze is increased in circulating lymphocytes of patients with chronic obstructive disease, asthma and chronic arthritis. Am J Resp Crit Care Med 2000; 161:32-35.
35. Busiere FI, Mazur A, Fauquert JL, Labbe A, Rayssiguier Y, Tridon A. High magnesium concentration in vitro decrease human leukocyte activation. Magnes Res 2002; 15(1-2):43-48.
36. Dominguez LJ, Barbagalo M, Di Lorenzo G, Drago A, Scola S, Morici G, Caruso C. Bronchial reactivity and intracellular magnesium: a possible role for the bronchodilating effects of magnesium in asthma. Clin Sci 1998; 95:137-142.
37. Fantidis P, Cacho JR, Marin M, Jarabo RM, Solera J, Herrero E. Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks. J R Soc Med 1995; 88:441-445.
38. Rowe B, Bretzlaff JA, Bota GW, Camargo CA. Intravenous magnesium sulphate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emer Med 2000; 36(3):181-190.
39. Skorodin MS, Tenholder MF, Yetter B. Magnesium sulphate in exacerbation of chronic obstructive pulmonary disease. Archive of internal medicine 1995; 155 (5):496-513.
40. Rolla G, Bucca C, Bugiani M, Oliva A, Brancifore L. Hypomagnesaemia in Chronic Obstructive Lung Disease: Effect of therapy. Magnesium Trace Elem 1990; 9:132-136.
41. Kurys E, Kurys P, Kierzko R. Analysis of antioxidant enzyme activity and magnesium level in chronic obstructive pulmonary disease. Annals Universitatis Mariae Curie Lublin 2001; 42:262-265.
42. Buhl R, Farmer SG. Future direction in the pharmacologic therapy of chronic obstructive disease. Proc Amer Thoracic Soc 2005; 2:83-93.
43. Durlach J, Pages N, Bac P, Bara M, Guiet-Bara A. Beta2-mimetics and magnesium: true or false friends? Magnes Res 2003; 16(3):218-233.